HighTide Therapeutics’ HTD1801 Demonstrates Reduced Liver Fat, Improved Glycemic Control and Other Health Measures in Diabetic NASH Patients
-- Phase 2 Data Published Online in Nature Communications -- SHENZHEN, China & ROCKVILLE, Md.--(BUSINESS…
-- Phase 2 Data Published Online in Nature Communications -- SHENZHEN, China & ROCKVILLE, Md.--(BUSINESS…
Fortune 500 firms take preemptive action to prevent officism from having negative effects on company…
Paycor’s mobile-friendly immunization tracker helps businesses record and report compliance with the new vaccine mandate.…
A Standard Chartered survey reveals that US companies are highly optimistic about growth in ASEAN…
SAN FRANCISCO--(BUSINESS WIRE)--#agexpansion--Andersen Global continues its expansion in Asia through a Collaboration Agreement with Malaysian-based…
NEW YORK--(BUSINESS WIRE)--New Fortress Energy Inc. (NASDAQ: NFE) (“New Fortress”) and The Government of the…
TOKYO & NEW YORK--(BUSINESS WIRE)--MUFG and MUFG Bank, a core banking subsidiary of MUFG, today…
KITCHENER, Ontario--(BUSINESS WIRE)--#Neo--Avidbots, one of the world’s leading robotics companies, announced today the launch of…
Mawson to lease six acres with up to 100MW of capacity, with opportunity to expand…
HCL will establish fintech lab in Germany to drive innovation and create transformational technology architectures…